We have located links that may give you full text access.
Case Reports
Journal Article
A giant aggressive angiomyxoma of vulva in a young woman: A case report.
Medicine (Baltimore) 2019 January
RATIONALE: Aggressive angiomyxoma (AAM) is a rare and benign invasive mesenchymal stromal tumor predominantly in women at reproductive age. AAM tends to relapse locally and should be differentially diagnosed from other mesenchymal tumors.
PATIENT CONCERNS: We report here a rare case of massive vulvar AAM in a 22-year-old Chinese woman with left labia majora mass with ulcer.
DIAGNOSES: The diagnosis "aggressive angiomyxoma of vulva" was based on clinicopathologic and immunohistochemical features.
INTERVENTIONS: A surgery with local excision of the mass was performed.
OUTCOMES: The patient was discharged 12 days after the surgery. There was no AAM recurrence or metastasis in a period of 12-month follow-up.
LESSONS: The vulvar AAM is a benign and aggressive mesenchymal tumor. In this case, we present the diagnosis, treatment, and prognosis for vulvar AAM. The tumor was removed completely by the surgery, but a long-term follow-up is requisite for surveilling on recurrence.
PATIENT CONCERNS: We report here a rare case of massive vulvar AAM in a 22-year-old Chinese woman with left labia majora mass with ulcer.
DIAGNOSES: The diagnosis "aggressive angiomyxoma of vulva" was based on clinicopathologic and immunohistochemical features.
INTERVENTIONS: A surgery with local excision of the mass was performed.
OUTCOMES: The patient was discharged 12 days after the surgery. There was no AAM recurrence or metastasis in a period of 12-month follow-up.
LESSONS: The vulvar AAM is a benign and aggressive mesenchymal tumor. In this case, we present the diagnosis, treatment, and prognosis for vulvar AAM. The tumor was removed completely by the surgery, but a long-term follow-up is requisite for surveilling on recurrence.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app